BIO5 members Lalitha Madhavan and Robin Polt are part of a group of researchers who published a study finding that a tiny protein called PNA5 appears to have a protective effect on brain cells, which could lead to treatments for the cognitive symptoms of Parkinson’s disease and related disorders.

BIO5 member Jonathan Lifshitz, a research professor of psychiatry at the University of Arizona College of Medicine – Phoenix, was appointed a member of the National Institute of Neurological Disorders and Stroke’s Neurological Sciences and Disorders study section initial review group at the National Institutes of Health.

See examples of University of Arizona research projects during the KEYS Research Internship that trains the next generation of innovators.